Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Isaacs

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Nonalcoholic Fatty Liver DiseaseScott Isaacs
Diabetes & Metabolic Syndrome|May 7, 2024
Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetiromMohammad Shafi Kuchay, Scott Isaacs, Anoop Misra
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 5, 2023
Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology ClinicsZobair M Younossi, Linda Henry, Scott Isaacs, et al.
Alimentary Pharmacology & Therapeutics|December 13, 2022
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitisZobair Younossi, Naim Alkhouri, Ken Cusi, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 15, 2022
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery diseaseJacob J Gries, Jeffrey V Lazarus, Paul N Brennan, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
Journal of Diabetes and Its Complications|April 30, 2025
Obesity and its management in primary care settingMahmoud Ibrahim, Ebtesam M Ba-Essa, Jessica A Alvarez, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Nonalcoholic Fatty Liver DiseaseScott Isaacs
Diabetes & Metabolic Syndrome|May 7, 2024
Intrahepatic hypothyroidism in MASLD: Role of liver-specific thyromimetics including resmetiromMohammad Shafi Kuchay, Scott Isaacs, Anoop Misra
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 5, 2023
Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology ClinicsZobair M Younossi, Linda Henry, Scott Isaacs, et al.
Alimentary Pharmacology & Therapeutics|December 13, 2022
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitisZobair Younossi, Naim Alkhouri, Ken Cusi, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 15, 2022
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery diseaseJacob J Gries, Jeffrey V Lazarus, Paul N Brennan, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
Journal of Diabetes and Its Complications|April 30, 2025
Obesity and its management in primary care settingMahmoud Ibrahim, Ebtesam M Ba-Essa, Jessica A Alvarez, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Pageof 1